Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Hurwitz

Showing results (161-170 of 182) with videos related to

Pageof 19
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2007
Phase II trial of sunitinib in patients with metastatic colorectal cancer after failure of standard therapyLeonard B Saltz, Lee S Rosen, John L Marshall, et al.
Nucleic Acids Research|December 1, 2012
CDD: conserved domains and protein three-dimensional structureAron Marchler-Bauer, Chanjuan Zheng, Farideh Chitsaz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2015
Randomized, Double-Blind, Phase II Study of Ruxolitinib or Placebo in Combination With Capecitabine in Patients With Metastatic Pancreatic Cancer for Whom Therapy With Gemcitabine Has FailedHerbert I Hurwitz, Nikhil Uppal, Stephanie A Wagner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2021
Plasma Protein Biomarkers in Advanced or Metastatic Colorectal Cancer Patients Receiving Chemotherapy With Bevacizumab or Cetuximab: Results from CALGB 80405 (Alliance)Andrew B Nixon, Alexander B Sibley, Yingmiao Liu, et al.
International Journal of Radiation Oncology, Biology, Physics|February 18, 2004
A Phase I trial of preoperative eniluracil plus 5-fluorouracil and radiation for locally advanced or unresectable adenocarcinoma of the rectum and colonBrian G Czito, Timothy J Hong, Darrel P Cohen, et al.
Molecular Cancer Research : MCR|March 9, 2016
Development of a Novel c-MET-Based CTC Detection PlatformTian Zhang, Rengasamy Boominathan, Brad Foulk, et al.
The Oncologist|March 25, 2018
A Phase I Trial of the IGF-1R Antibody Ganitumab (AMG 479) in Combination with Everolimus (RAD001) and Panitumumab in Patients with Advanced CancerGordana Vlahovic, Kellen L Meadows, Ace J Hatch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2012
Complete longitudinal analyses of the randomized, placebo-controlled, phase III trial of sunitinib in patients with gastrointestinal stromal tumor following imatinib failureGeorge D Demetri, Christopher R Garrett, Patrick Schöffski, et al.
Scientific Reports|November 7, 2018
Genetic variation determines VEGF-A plasma levels in cancer patientsFederico Innocenti, Chen Jiang, Alexander B Sibley, et al.
Nucleic Acids Research|November 22, 2014
CDD: NCBI's conserved domain databaseAron Marchler-Bauer, Myra K Derbyshire, Noreen R Gonzales, et al.
Pageof 19

Showing results (161-170 of 182) with videos related to

Sort By:
Pageof 19
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2007
Phase II trial of sunitinib in patients with metastatic colorectal cancer after failure of standard therapyLeonard B Saltz, Lee S Rosen, John L Marshall, et al.
Nucleic Acids Research|December 1, 2012
CDD: conserved domains and protein three-dimensional structureAron Marchler-Bauer, Chanjuan Zheng, Farideh Chitsaz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2015
Randomized, Double-Blind, Phase II Study of Ruxolitinib or Placebo in Combination With Capecitabine in Patients With Metastatic Pancreatic Cancer for Whom Therapy With Gemcitabine Has FailedHerbert I Hurwitz, Nikhil Uppal, Stephanie A Wagner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2021
Plasma Protein Biomarkers in Advanced or Metastatic Colorectal Cancer Patients Receiving Chemotherapy With Bevacizumab or Cetuximab: Results from CALGB 80405 (Alliance)Andrew B Nixon, Alexander B Sibley, Yingmiao Liu, et al.
International Journal of Radiation Oncology, Biology, Physics|February 18, 2004
A Phase I trial of preoperative eniluracil plus 5-fluorouracil and radiation for locally advanced or unresectable adenocarcinoma of the rectum and colonBrian G Czito, Timothy J Hong, Darrel P Cohen, et al.
Molecular Cancer Research : MCR|March 9, 2016
Development of a Novel c-MET-Based CTC Detection PlatformTian Zhang, Rengasamy Boominathan, Brad Foulk, et al.
The Oncologist|March 25, 2018
A Phase I Trial of the IGF-1R Antibody Ganitumab (AMG 479) in Combination with Everolimus (RAD001) and Panitumumab in Patients with Advanced CancerGordana Vlahovic, Kellen L Meadows, Ace J Hatch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2012
Complete longitudinal analyses of the randomized, placebo-controlled, phase III trial of sunitinib in patients with gastrointestinal stromal tumor following imatinib failureGeorge D Demetri, Christopher R Garrett, Patrick Schöffski, et al.
Scientific Reports|November 7, 2018
Genetic variation determines VEGF-A plasma levels in cancer patientsFederico Innocenti, Chen Jiang, Alexander B Sibley, et al.
Nucleic Acids Research|November 22, 2014
CDD: NCBI's conserved domain databaseAron Marchler-Bauer, Myra K Derbyshire, Noreen R Gonzales, et al.
Pageof 19